Skip to content
Thursday, May 26, 2022
Latest:
  • Research Spotlight: Dr. Fritz Sedlazeck assists in filling gaps in human genome, sequencing Rice University owl genome and more
  • Building community in Transition Medicine
  • Molecular profiling identifies new high-risk subtype of pediatric liver cancer
  • Celebrating Baylor College of Medicine Graduation 2022
  • Store food safely to avoid getting sick

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Kaylee Dusang
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

cancer transcriptomics

From The Labs 

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951